Letter: Hyperphosphatemia and hypocalcemia in myeloproliferative disorder.
D000328:Adult; D003561:Cytarabine / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy; D006996:Hypocalcemia / Q000209:etiology*; D008297:Male; D009196:Myeloproliferative Disorders / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D010710:Phosphates / Q000097:blood*; D010758:Phosphorus / Q000378:metabolism; D008926:Plicamycin / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013866:Thioguanine / Q000627:therapeutic use
D010710:Phosphates; D003561:Cytarabine; D010758:Phosphorus; D013866:Thioguanine; D008926:Plicamycin; D011241:Prednisone